Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 1/2019

Open Access 01-12-2019 | Glioblastoma | Original Article

Pre-operative apparent diffusion coefficient values and tumour region volumes as prognostic biomarkers in glioblastoma: correlation and progression-free survival analyses

Authors: Coral Durand-Muñoz, Eduardo Flores-Alvarez, Sergio Moreno-Jimenez, Ernesto Roldan-Valadez

Published in: Insights into Imaging | Issue 1/2019

Login to get access

Abstract

Objectives

Glioblastoma (GB) contains diverse histologic regions. Apparent diffusion coefficient (ADC) values are surrogates for the degree of number of cells within the tumour regions. Because an assessment of ADC values and volumes within tumour sub-compartments of GB is missing in the literature, we aimed to evaluate these associations.

Methods

A retrospective cohort of 48 patients with GB underwent segmentation to calculate tumour region volumes (in cubic centimetre) and ADC values in tumour regions: normal tissue, enhancing tumour, proximal oedema, distal oedema, and necrosis. Correlation, Kaplan-Meier, and Cox hazard regression analyses were performed.

Results

We found a statistically significant difference among ADC values for tumour regions: F (4, 220) = 166.71 and p ≤ .001 and tumour region volumes (necrosis, enhancing tumour, peritumoural oedema): F (2, 141) = 136.3 and p ≤ .001. Post hoc comparisons indicated that the only significantly different mean score was the peritumoural volume in oedema region (p < .001). We observed a positive significant correlation between ADC of distal oedema and peritumoural volume, r = .418, df = 34, and p = .011. Cox proportional hazards regression analysis considering only tumour region volumes provided an almost significant model: − 2 log-likelihood = 146.066, χ2 (4) = 9.303, and p = .054 with a trend towards significance of the hazard function: p = .067 and HR = 1.077 for the non-enhancing tumour volume.

Conclusions

ADC values together with volumes of oedema region might have a role as predictors of progression-free survival (PFS) in patients with GB; we recommend a routine MRI assessment with the calculation of these biomarkers in GB.
Literature
1.
Cortez-Conradis D, Favila R, Isaac-Olive K, Martinez-Lopez M, Rios C, Roldan-Valadez E (2013) Diagnostic performance of regional DTI-derived tensor metrics in glioblastoma multiforme: simultaneous evaluation of p, q, L, Cl, Cp, Cs, RA, RD, AD, mean diffusivity and fractional anisotropy. Eur Radiol 23:1112–1121CrossRef
2.
Rees JH, Smirniotopoulos JG, Jones RV, Wong K (1996) Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics 16:1413–1438 quiz 1462-1413CrossRef
3.
Elson A, Bovi J, Siker M, Schultz C, Paulson E (2015) Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. J Neurooncol 122:549–558
4.
Holland EC (2001) Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2:120–129CrossRef
5.
Roldan-Valadez E, Rios C, Motola-Kuba D, Matus-Santos J, Villa AR, Moreno-Jimenez S (2016) Choline-to-N-acetyl aspartate and lipids-lactate-to-creatine ratios together with age assemble a significant Cox's proportional-hazards regression model for prediction of survival in high-grade gliomas. Br J Radiol 89:20150502CrossRef
6.
Roldan-Valadez E, Rios C, Cortez-Conradis D, Favila R, Moreno-Jimenez S (2014) Global diffusion tensor imaging derived metrics differentiate glioblastoma multiforme vs. normal brains by using discriminant analysis: introduction of a novel whole-brain approach. Radiol Oncol 48:127–136CrossRef
7.
Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60CrossRef
8.
Higano S, Yun X, Kumabe T et al (2006) Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 241:839–846CrossRef
9.
Murakami R, Sugahara T, Nakamura H et al (2007) Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 243:493–499CrossRef
10.
Meier R, Knecht U, Loosli T et al (2016) Clinical evaluation of a fully-automatic segmentation method for longitudinal brain tumor volumetry. Sci Rep 6:23376CrossRef
11.
Gutman DA, Cooper LA, Hwang SN et al (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267:560–569CrossRef
12.
Lim DA, Cha S, Mayo MC et al (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9:424–429
13.
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRef
14.
15.
Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRef
16.
Pallant J (2011) One-way analysis of variance. In: Pallant J (ed) SPSS Survival Manual. Allen & Unwin, Crows Nest, pp 249–264
17.
Tabachnik BG, Fidell SL (2013) Review of univariate and bivariate statistics. In: Tabachnik BG, Fidell SL (eds) Using multivariate statistics. Pearson Education. Inc., Boston, MA, pp 33–59
18.
Pfister R, Janczyk M (2013) Confidence intervals for two sample means: calculation, interpretation, and a few simple rules. Adv Cogn Psychol 9:74–80CrossRef
19.
Cohen JW (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, NJ
20.
Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ (2011) Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract 119:c83–c88CrossRef
21.
Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ (2011) Survival analysis II: Cox regression. Nephron Clin Pract 119:c255–c260CrossRef
22.
Tugcu B, Postalci LS, Gunaldi O, Tanriverdi O, Akdemir H (2010) Efficacy of clinical prognostic factors on survival in patients with glioblastoma. Turk Neurosurg 20:117–125PubMed
23.
Yaneva MP, Semerdjieva ML, Radev LR, Vlaikova MI (2010) Postoperative chemo-radiotherapy with temodal in patients with glioblastoma multiforme--survival rates and prognostic factors. Folia Med (Plovdiv) 52:26–33
24.
Seidel C, Dörner N, Osswald M et al (2011) Does age matter? - a MRI study on peritumoral edema in newly diagnosed primary glioblastoma. BMC Cancer 11:127
25.
Schoenegger K, Oberndorfer S, Wuschitz B et al (2009) Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol 16:874–878CrossRef
26.
Bai Y, Lin Y, Tian J et al (2016) Grading of gliomas by using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging and diffusion kurtosis MR imaging. Radiology 278:496–504CrossRef
27.
Lutz K, Wiestler B, Graf M et al (2014) Infiltrative patterns of glioblastoma: identification of tumor progress using apparent diffusion coefficient histograms. J Magn Reson Imaging 39:1096–1103CrossRef
28.
Ellingson BM, Gerstner ER, Smits M et al (2017) Diffusion MRI phenotypes predict overall survival benefit from anti-VEGF monotherapy in recurrent glioblastoma: converging evidence from phase II trials. Clin Cancer Res 23:5745–5756CrossRef
29.
Henker C, Kriesen T, Fürst K et al (2016) Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme. J Neurooncol 126:585–592
30.
31.
Reimer C, Deike K, Graf M et al (2017) Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps. PLoS One 12:e0174620CrossRef
32.
Huang RY, Neagu MR, Reardon DA, Wen PY (2015) Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response. Front Neurol 6:33CrossRef
33.
Wu CX, Lin GS, Lin ZX et al (2015) Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma. Oncol Lett 10:2769–2776CrossRef
34.
Ellingson BM, Cloughesy TF, Lai A et al (2011) Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13:1151–1161
35.
Romano A, Calabria LF, Tavanti F et al (2013) Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. Eur Radiol 23:513–520CrossRef
36.
Johnson PC, Hunt SJ, Drayer BP (1989) Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology 170:211–217CrossRef
37.
38.
Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34:463–469CrossRef
39.
Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865–874CrossRef
40.
Hoe Y, Choi YJ, Kim JH, Kwon DH, Kim CJ, Cho YH (2015) Peritumoral brain edema after stereotactic radiosurgery for asymptomatic intracranial meningiomas: risks and pattern of evolution. J Korean Neurosurg Soc 58:379–384
41.
Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13:1339–1348
42.
Nael K, Bauer AH, Hormigo A et al (2018) Multiparametric MRI for differentiation of radiation necrosis from recurrent tumor in patients with treated glioblastoma. AJR Am J Roentgenol 210:18–23CrossRef
43.
Leimgruber A, Ostermann S, Yeon EJ et al (2006) Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. Int J Radiat Oncol Biol Phys 64:869–875CrossRef
Metadata
Title
Pre-operative apparent diffusion coefficient values and tumour region volumes as prognostic biomarkers in glioblastoma: correlation and progression-free survival analyses
Authors
Coral Durand-Muñoz
Eduardo Flores-Alvarez
Sergio Moreno-Jimenez
Ernesto Roldan-Valadez
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2019
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-019-0724-8

Other articles of this Issue 1/2019

Insights into Imaging 1/2019 Go to the issue

Correction

Correction to: A panorama of radial nerve pathologies- an imaging diagnosis: a step ahead

Critical Review

Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review

Critical Review

Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement

Pictorial Review

Imaging of cranial nerves: a pictorial overview

Review

Thyroglossal duct pathology and mimics

Review

Techniques and future perspectives for the prevention and treatment of endoleaks after endovascular repair of abdominal aortic aneurysms